Europe Could Conditionally Approve Gilead’s Remdesivir In Next Few Days

Most visited

1 year ago full article

share

Guido Rasi, the Executive Director of the European Medicines Agency (EMA), has suggested that Gilead’s (GILD) Covid-19 treatment remdesivir could be conditionally approved in Europe as soon as this week.“It might be that a conditi ...Read More

140o

68%
Menu

Leave a Comment